Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections
The WHO Department leads the global effort to end the epidemics of HIV, tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs), ensuring that every person has equitable access to highest-quality people-centred scientific evidence and services, regardless of who they are or where they live.

 

Featured


Global Health Sector Strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030 (GHSS)

Global health sector strategies guide the health sector in implementing strategically focused responses to achieve the goals of ending AIDS, viral hepatitis B and C and sexually transmitted infections by 2030.

EndTB2

Ending TB is not just a public health problem, but a development challenge and opportunity. WHO’s post-2015 End TB Strategy, adopted by the World Health Assembly in 2014, aims to end the global TB epidemic as part of the newly adopted Sustainable Development Goals.

Illustration with circles and arrows

At-a-glance accountability dashboard for progress on global strategies for HIV, Hepatitis and STIs with status on impact indicators, services delivered, and adoption of WHO policies. Country scorecards measure progress towards HIV incidence and mortality, and reaching service targets.

 

 

Publications

All →
Consolidated guidance on hepatitis B and C prevention, testing, treatment, service delivery and monitoring: an implementation handbook for a public health approach

This document consolidates, for the first time, WHO recommendations on the prevention, testing, treatment and monitoring of hepatitis B and C, and...

WHO consolidated operational handbook on sexually transmitted infections

WHO's Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections (STIs) has consolidated all existing normative guidance on STIs...

Needle and syringe programmes for people who inject drugs: operational guide

This operational guide provides practical, evidence-based guidance to support countries in planning, implementing and scaling up needle and syringe programmes...

WHO updated recommendations on HIV clinical management: recommendations for a public health approach

This document provides an overview of the updated World Health Organization recommendations for HIV clinical management, which focus on optimizing antiretroviral...

Guidance on evidence generation on new regimens for tuberculosis preventive treatment

The Guidance on evidence generation (GEG) on new regimens for tuberculosis preventive treatment (TPT) advises researchers, developers,...

WHO guidelines on the management of advanced HIV disease

Advanced HIV disease is the major cause of AIDS-related deaths among people living with HIV. In 2017, WHO recommended a package of care that should ...

WHO consultation on the use of broadly neutralizing antibodies for postnatal prophylaxis against the vertical transmission of HIV: meeting report, 22–23 May and 25 November 2024

Building on growing momentum from multiple stakeholders, this report summarizes the proceedings from a consultation held to convene a multidisciplinary...

Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030

The Integrated Drug Resistance Action Framework for HIV, Hepatitis B and C, and Sexually Transmitted Infections (2026–2030) outlines a unified...